ARCHIVES

Most of NCI’s $60 Million Increase In FY95 will fund Mandatory Raise In Prevention

This article is from The Cancer Letter archive.

Vol. 20 No. 39 | October 14, 1994

Download PDF Visit The Full Archive

Related Articles

Mass. ACS Offers Three Programs For Young Investigators

July 24, 1987

Amgen Claimed QOL Benefit Despite FDA Label Change.

May 18, 2007

Study Tracks Lifestyle Factors For Cancer Burden In Blacks

October 26, 2001

Clinical Oncology Program Overview Updates Ongoing Trials

December 8, 1989

CCRU-CCSP Report At Closed Session “Declassified” Discusses Review

December 3, 1982

Clinical Trials Approved By NCI

November 28, 2003